ARTICLE | Targets & Mechanisms
PureTech plumbs the brain
Why PureTech is targeting brain lymphatics to treat neurodegeneration
July 26, 2018 11:57 PM UTC
PureTech Health plc is backing a new way of thinking about Alzheimer’s disease that positions it primarily as a problem of poor drainage, building on the recent discovery of lymphatic vessels in the brain by Jonathan Kipnis at the University of Virginia.
The company licensed the IP from UVA and will collaborate with the academic group to develop modulators of brain lymphatic vessels. Terms of the deal are undisclosed...